Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Don't Floss, You Lose - (ATRX) To the RESCUE. -- Ignore unavailable to you. Want to Upgrade?

To: Dan B. who wrote (62)	2/28/1999 8:42:00 AM
From: Arthur Radley	Read Replies (1) \| Respond to of 182

Well stated! The caveats placed on the Atridox product, I sure, are similar to what you will find on most medical products. The point is....finally there is an alternative to the SRP treatment method. Does this mean that SRP will go away as a treatment method? The answer is an obvious NO. I would also like to respond to Lloy's question about where does the plaque and bacteria go when Atridox is used. Actually, the question is where do they go when the SRP method is used and the answer is probably into the blood system and we know now that there can be complications from this relating to heart disease.